Dolutegravir Sodium
Brand name: Tivicay
Rank #76 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$251.7M
Total Cost
102,995
Total Claims
$251.7M
Total Cost
2,253
Prescribers
$2,444
Cost per Claim
6,687
Beneficiaries
106,915
30-Day Fills
$112K
Avg Cost/Provider
46
Avg Claims/Provider
Share of Medicare Part D Spending
0.09%
of total Medicare Part D spending
$251.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $251.7M total
🔎 Data Overview
At $2,444 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $111,740 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $37,648 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Dolutegravir Sodium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sharon Reiley | Nurse Practitioner | Jacksonville, FL | 904 | $2.1M |
| 2 | Jihad Slim | Infectious Disease | Newark, NJ | 521 | $1.2M |
| 3 | Clayton Barbour | Internal Medicine | Cathedral City, CA | 459 | $1.2M |
| 4 | Margaret Gorensek | Infectious Disease | Fort Lauderdale, FL | 400 | $1.1M |
| 5 | Marc Johnson | Internal Medicine | Charlotte, NC | 439 | $1.0M |
| 6 | Natalie Vanek | Infectious Disease | Houston, TX | 415 | $989K |
| 7 | Stephanie Skipper | Nurse Practitioner | Orlando, FL | 388 | $976K |
| 8 | William Briggs | Physician Assistant | Louisville, KY | 392 | $891K |
| 9 | Molly Stenzel | Infectious Disease | Portland, OR | 132 | $844K |
| 10 | Joseph Gathe | Infectious Disease | Houston, TX | 269 | $817K |
| 11 | Pablo Pella | Infectious Disease | Jacksonville, FL | 338 | $809K |
| 12 | Mark Higgins | Internal Medicine | San Francisco, CA | 282 | $803K |
| 13 | Federico Hinestrosa | Infectious Disease | Orlando, FL | 305 | $767K |
| 14 | Karam Mounzer | Internal Medicine | Philadelphia, PA | 277 | $749K |
| 15 | Jonell Poe | Physician Assistant | Augusta, GA | 306 | $722K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
| 75 | Metoprolol Succinate (Metoprolol Succinate) | $256.3M | 12,847,535 |
| 76 | Dolutegravir Sodium (Tivicay) | $251.7M | 102,995 |
| 77 | Abemaciclib (Verzenio) | $242.2M | 16,125 |
| 78 | Abacavir/Dolutegravir/Lamivudi (Triumeq) | $238.1M | 61,147 |
| 79 | Riociguat (Adempas) | $236.6M | 17,620 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology